Actos Lawsuits Mount as Claims in Federal Actos Bladder Cancer Litigation Near 2,700, Bernstein Liebhard LLP Reports

The Firm is evaluating Actos lawsuits on behalf of long-term users of the drug who have been diagnosed with bladder cancer.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm continues to hear from Actos users who were diagnosed with bladder cancer, allegedly following long-term use of this drug. It’s not surprising that the number of claims filed in the federal proceeding is nearing 2,700.

New York, New York (PRWEB) January 19, 2014

Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) that allege long-term use of the Type II diabetes drug caused patients to develop bladder cancer continue to mount in the federal multidistrict litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to an updated case list issued by the U.S. Judicial Panel on Multidistrict Litigation on January 15, 2014, 2,692 Actos bladder cancer claims have been filed in the proceeding. Court documents indicate that the litigation is preparing to hold its first bellwether trial on January 27, 2014. (In re: Actos Product Liability Litigation, MDL No. 2299)

“Our Firm continues to hear from Actos users who were diagnosed with bladder cancer, allegedly following long-term use of this drug. It’s not surprising that the number of claims filed in the federal proceeding is nearing 2,700,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to individuals who were treated with Actos for a year or more, and who allegedly went on to develop bladder cancer due to their use of the drug.

Actos Lawsuits
According to court documents, all of the Actos lawsuits pending in the Western District of Louisiana allege that Takeda Pharmaceuticals concealed knowledge of the drug’s association with bladder cancer, and failed to provide doctors and patients with adequate warnings regarding this risk.

In 2013, three Actos lawsuits went to trial at the state court level, court records indicate. In April, an Actos bladder cancer plaintiff was awarded more than $6.5 million by a Los Angeles Superior Court Jury in September. However, that verdict was set aside by the judge overseeing the case, and is currently on appeal. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)

In September, a Maryland State Court jury awarded $1.7 million to the family of a man who died of bladder cancer following long-term use of Actos. However, the judge presiding over the lawsuit overturned the verdict because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)

Most recently, an Actos bladder cancer trial concluded in December, with a Nevada jury finding for the defense. (Alsabagh v. Takeda Pharmaceuticals America Inc., A-12-665708-C, Clark County District Court, Nevada (Las Vegas))

The Actos litigation has been growing since June 2011, when the U.S. Food & Drug Administration (FDA) mandated that new information regarding the drug’s association with bladder cancer be added to the “Warnings and Precautions” section of the Actos label. At the same time, the agency warned that those patients who took Actos for a year or more could face an increased risk of developing the potentially fatal disease.

Actos users who may have developed bladder cancer due to their use of the Type II diabetes drug could be entitled to compensation for medical bills, lost wages, pain and suffering and more. To find out more about the potential for Actos to cause bladder cancer, please visit Bernstein Liebhard LLP’s website. For additional information, please call 800-511-5092 today.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author